JPRN-UMIN000027371
Recruiting
未知
Research for evaluation of efficacy and safety of DAA therapy in HIV/HCV co-infected patients disorders - Research of DAA therapy in HIV/HCV co-infected patients
ational Center for Global Health and Medicine0 sites100 target enrollmentMay 23, 2017
ConditionsChronic hepatitis C
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Chronic hepatitis C
- Sponsor
- ational Center for Global Health and Medicine
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with non\-compensated cirrhosis Patients with severe renal impairment (eGFR\<30ml/minute/1\.73m2\) Patients with HBs antigen positive Patients who have active opportunistic infection Other drugs are adequate for the patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
study on overall improvement of Skin ParametersCTRI/2023/06/054242Transformative Learning Solutions Pvt Ltd75
Active, not recruiting
Phase 1
A Study to Evaluate the Safety and efficacy of the Antibody APX005M in Adult Patients with Metastatic Melanoma Who have not Received Prior Immunotherapynresectable or metastatic melanomaMedDRA version: 20.0 Level: LLT Classification code 10027481 Term: Metastatic melanoma System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-003864-30-ESApexigen, Inc.36
Recruiting
Not Applicable
A exploratory study of the efficacy and safety of oxaliplatin in combination with S-1 in the treatment of non-resectable gastric cancernon-resectable gastric cancer or reccurent gastric cancerJPRN-UMIN000002463niversity of Tokyo Hospital20
Recruiting
Not Applicable
An exploratory study on the efficacy and safety of Hangesyasinto (TJ-14) for DCF chemotherapy or DCF-RT chemoradiotherapy induced diarrhea in the patients with advanced esophageal cancer.JPRN-UMIN000023825Dokkyo Medical University24
Recruiting
Phase 2
An exploratory study of the safety and efficacy of disulfiram in progressive fibrosing interstitial lung diseaseprogressive fibrosing interstitial lung diseaseinterstitial lung diseaseD017563JPRN-jRCTs031220648rushiyama Hirokazu10